Amikacin is also known by its brand name, Amikin [1].
Why Do Drugs Have Multiple Names?
Drugs are often referred to by different names due to their chemical structure and commercial marketing. The generic name, such as amikacin, is its official scientific name, while brand names like Amikin are developed by pharmaceutical companies for marketing purposes [1]. This can sometimes lead to confusion for patients and healthcare providers [2].
When Was Amikacin First Approved?
Amikacin was first approved by the U.S. Food and Drug Administration (FDA) in 1979 [3].
What Is Amikacin Used For?
Amikacin is an aminoglycoside antibiotic used to treat serious bacterial infections [4]. It is effective against a range of Gram-negative bacteria and some Gram-positive bacteria [4]. It is typically administered in a hospital setting via injection [4].
Are There Other Aminoglycoside Antibiotics?
Yes, other aminoglycoside antibiotics include gentamicin, tobramycin, streptomycin, and kanamycin [5]. These drugs share a similar mechanism of action, which involves inhibiting bacterial protein synthesis [5]. However, they can differ in their spectrum of activity, potency, and side effect profiles [5].
What Are the Risks of Using Amikacin?
Like other aminoglycosides, amikacin carries risks of nephrotoxicity (kidney damage) and ototoxicity (damage to the hearing or balance system) [4]. These risks can be influenced by factors such as dosage, duration of treatment, and pre-existing kidney or hearing impairments [4]. Close monitoring of kidney function and hearing is crucial during treatment [4].
Can Amikacin Be Used During Pregnancy?
Amikacin is generally not recommended during pregnancy due to potential risks to the fetus, including ototoxicity [4]. Decisions regarding its use in pregnant individuals are made on a case-by-case basis, weighing the potential benefits against the risks [4].